https://www.biospace.com/data-from-long-term-safety-study-support-chronic-use-of-arq-151-topical-roflumilast-cream-as-a-potential-treatment-for-plaque-psoriasis
Data from Long-Term Safety Study Support Chronic Use of ARQ-151 (Topical Roflumilast Cream) as a...
Dec 2, 2020 - Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in...
topical roflumilast creamlong termstudy supportdatasafety